A Systematic Review and Meta-Analysis of Randomized Controlled Trials in Use of GLP-1 Receptor Agonist in Type 1 Diabetes Mellitus

被引：0
|
作者：
Panta, Raju
Kunwar, Sumit
Batra, Manav
Ghimire, Dipesh K. C.
Mudgal, Mayuri
Makdissi, Antoine
Chaudhuri, Ajay
Dandona, Paresh
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1156-P
引用
收藏
页码：A308 / A308
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of teplizumab in the treatment of type 1 diabetes mellitus: An updated systematic review and meta-analysis of randomized controlled trials
    Alves, Gabriel Grando
    Cunha, Luisa
    Machado, Rafael Henkes
    de Menezes, Vanessa Lins
    [J]. DIABETES OBESITY & METABOLISM, 2024, 26 (07): : 2652 - 2661
  • [32] Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis
    Stefanou, Maria-Ioanna
    Theodorou, Aikaterini
    Malhotra, Konark
    Aguiar de Sousa, Diana
    Katan, Mira
    Palaiodimou, Lina
    Katsanos, Aristeidis H.
    Koutroulou, Ioanna
    Lambadiari, Vaia
    Lemmens, Robin
    Giannopoulos, Sotirios
    Alexandrov, Andrei, V
    Siasos, Gerasimos
    Tsivgoulis, Georgios
    [J]. EUROPEAN STROKE JOURNAL, 2024, 9 (03) : 530 - 539
  • [33] GLP-1 agonists for obesity and type 2 diabetes in children: Systematic review and meta-analysis
    Chadda, Karan R.
    Cheng, Tuck Seng
    Ong, Ken K.
    [J]. OBESITY REVIEWS, 2021, 22 (06)
  • [34] The Antiobesity Effect and Safety of GLP-1 Receptor Agonist in Overweight/Obese Patients Without Diabetes: A Systematic Review and Meta-Analysis
    Guo, Xiaonan
    Zhou, Zhibo
    Lyu, Xiaorui
    Xu, Hanyuan
    Zhu, Huijuan
    Pan, Hui
    Wang, Linjie
    Yang, Hongbo
    Gong, Fengying
    [J]. HORMONE AND METABOLIC RESEARCH, 2022, 54 (07) : 458 - 471
  • [35] GLP-1 receptor agonist on cardiovascular complications of diabetes mellitus
    Liu, Fengjun
    Kong, Yanhua
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (03) : 2259 - 2265
  • [36] The Effect of Metformin on Adolescents with Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Liu, Wei
    Yang, Xiao-Jie
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2016, 2016
  • [37] Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
    Sattar, Naveed
    Lee, Matthew M. Y.
    Kristensen, Soren L.
    Branch, Kelley R. H.
    Del Prato, Stefano
    Khurmi, Nardev S.
    Lam, Carolyn S. P.
    Lopes, Renato D.
    McMurray, John J., V
    Pratley, Richard E.
    Rosenstock, Julio
    Gerstein, Hertzel C.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (10): : 653 - 662
  • [38] Baduanjin Exercise for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Wen, Junmao
    Lin, Tong
    Cai, Yinhe
    Chen, Qianying
    Chen, Yuexuan
    Ren, Yueyi
    Weng, Senhui
    Wang, Boqing
    Ji, Shuliang
    Wu, Wei
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 2017
  • [39] GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials
    Kapoor, Ishani
    Sarvepalli, Swara M.
    D'Alessio, David
    Grewal, Dilraj S.
    Hadziahmetovic, Majda
    [J]. SURVEY OF OPHTHALMOLOGY, 2023, 68 (06) : 1071 - 1083
  • [40] Meta-analysis of GLP-1 agonist lixisenatide use in patients insufficiently controlled with OADs
    Raccah, D.
    Ceriello, A.
    Gourdy, P.
    Sagnard, L.
    Lin, J.
    Rosenstock, J.
    [J]. DIABETOLOGIA, 2013, 56 : S362 - S362
12345